Frontiers | High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
Low-Dose Lopinavir/Ritonavir Tablet Noninferior to Full Dose in Thai Children
Low-Dose Lopinavir/Ritonavir Tablet Noninferior to Full Dose in Thai Children
Ombitasvir-Paritaprevir-Ritonavir Technivie - Treatment - Hepatitis C Online
Lopinavir-Ritonavir Kaletra - Treatment - National HIV Curriculum
Bioequivalence Study of Two Fixed Dose Combination Tablet Formulations of Lopinavir and Ritonavir in Healthy Volunteers
Re: Acknowledgement of human bioequivalency of matrix's lopinavir–ritonavir formulation to Kaletra®, comment to article on bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al. -
Lopinavir - an overview | ScienceDirect Topics
Once-Daily PREZISTA®: Dosing for Treatment-Naïve Adults | PREZISTA® (darunavir)
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective | Psychiatrist.com
Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam | PLOS ONE
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effec
Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam | PLOS ONE
Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap
PulmCrit - Preview of Lopinavir/Ritonavir efficacy in COVID-19?
Use of WHO paediatric weight-band dosing in drug labels - The Lancet HIV